Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
1.040
+0.259 (33.13%)
At close: Nov 7, 2025, 4:00 PM EST
0.9990
-0.0410 (-3.94%)
After-hours: Nov 7, 2025, 6:41 PM EST
Femasys Market Cap
Femasys has a market cap or net worth of $44.73 million as of November 7, 2025. Its market cap has increased by 55.96% in one year.
Market Cap
44.73M
Enterprise Value
38.23M
1-Year Change
55.96%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on June 18, 2021, Femasys's market cap has decreased from $152.90M to $44.73M, a decrease of -70.75%. That is a compound annual growth rate of -24.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 33.60M | 33.39% |
| Dec 31, 2024 | 25.19M | 19.33% |
| Dec 29, 2023 | 21.11M | 98.53% |
| Dec 30, 2022 | 10.63M | -76.90% |
| Dec 31, 2021 | 46.02M | -69.90% |
| Jun 18, 2021 | 152.90M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |